Cargando…

Centrally and peripherally altered glucose transporters: is it time to revisit energy deficiency as a potential treatment strategy in Huntington's disease?

Detalles Bibliográficos
Autor principal:	Björkqvist, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694065/ https://www.ncbi.nlm.nih.gov/pubmed/37979315 http://dx.doi.org/10.1016/j.ebiom.2023.104882

Ejemplares similares

Abnormal peripheral chemokine profile in Huntington’s disease
por: Wild, Edward, et al.
Publicado: (2011)

RNA-editing in Basidiomycota, revisited
por: Min, Byoungnam, et al.
Publicado: (2021)

Dual Therapy with Liraglutide and Ghrelin Promotes Brain and Peripheral Energy Metabolism in the R6/2 Mouse Model of Huntington’s Disease
por: Duarte, Ana I., et al.
Publicado: (2018)

Time to revisit the use of G-CSF after allogeneic haematopoietic cell transplantation in COVID-19 era?
por: Malek, Alexandre E.
Publicado: (2021)

Sodium‑glucose co-transporter‑2 inhibitors in the treatment of diabetes with heart failure
por: Liang, Bo, et al.
Publicado: (2022)

Revisiting the initial COVID-19 pandemic projections
por: Biggs, Adam T, et al.
Publicado: (2021)

Revisiting the neuropsychiatry of Huntington's disease
por: Teixeira, Antonio Lucio, et al.
Publicado: (2016)

Does rural primary care ophthalmology teaching need revisiting?
por: Patel, Chirag
Publicado: (2020)

Myocardial performance index: Is it time to revisit this old parameter in COVID-19 patients?
por: Timóteo, Ana Teresa
Publicado: (2022)

Revisiting the diagnosis of ‘resistant hypertension’: what should we do nowadays’
por: Alsharari, Reem, et al.
Publicado: (2021)

Facilitating Huntington's disease research: plasma neurofilament levels as a promising enrichment biomarker for HD-ISS stage 1
por: Sampaio, Cristina, et al.
Publicado: (2023)

Is it time to reconsider measles, mumps, and rubella immunisation strategies?
por: Boccalini, Sara, et al.
Publicado: (2021)

Coronary physiology revisited
por: Piek, J. J.
Publicado: (2017)

Energy restriction in people with multiple sclerosis: Is time more important than calories?
por: Ghezzi, Laura
Publicado: (2022)

Characterization of Gastric Mucosa Biopsies Reveals Alterations in Huntington's Disease
por: McCourt, Andrew C, et al.
Publicado: (2015)

Serum levels of a subset of cytokines show high interindividual variability and are not altered in rats transgenic for Huntington´s disease
por: Nguyen, Huu Phuc, et al.
Publicado: (2010)

A Critical Evaluation of Wet Biomarkers for Huntington’s Disease: Current Status and Ways Forward
por: Silajdžić, Edina, et al.
Publicado: (2018)

Therapeutic strategies for glucose transporter 1 deficiency syndrome
por: Tang, Maoxue, et al.
Publicado: (2019)

SARS-CoV-2 transmission: time to rethink public health strategy
por: Parker, Arifa, et al.
Publicado: (2022)

Comment to: “Cluster failure revisited: Impact of first level design and physiological noise on cluster false positive rates”
por: Kiviniemi, Vesa
Publicado: (2019)

Evaluating the current state of the art of Huntington disease research: a scientometric analysis
por: Barboza, L.A., et al.
Publicado: (2018)

Comment on “Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity” Antioxidants 2020, 9, 594
por: Stehr, Jan Eric, et al.
Publicado: (2020)

Euglycemic diabetic ketoacidosis by sodium glucose co-transporter inhibitors: Real but preventable concern
por: Raut, Monish S, et al.
Publicado: (2017)

Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease
por: Henningsen, Jo B., et al.
Publicado: (2021)

Future urban transport management
por: Gao, Ziyou, et al.
Publicado: (2023)

Renal denervation revisited; should we pay attention?
por: de Winter, R. J.
Publicado: (2022)

Alterations in the respiratory tract microbiome in COVID-19: current observations and potential significance
por: Merenstein, Carter, et al.
Publicado: (2022)

RAGE regulates oxytocin transport into the brain
por: Yamamoto, Yasuhiko, et al.
Publicado: (2020)

Exciton transport in atomically thin semiconductors
por: Malic, Ermin, et al.
Publicado: (2023)

Communication is central to the mission of science
por: Contera, Sonia
Publicado: (2021)

Leptin-deficient mice are not hypothermic, they are anapyrexic
por: Fischer, Alexander W., et al.
Publicado: (2016)

Hypothalamic expression of huntingtin causes distinct metabolic changes in Huntington's disease mice
por: Dickson, Elna, et al.
Publicado: (2022)

Euploidy in somatic cells from R6/2 transgenic Huntington's disease mice
por: Petersén, Åsa, et al.
Publicado: (2005)

Myocardial infarction in the COVID-19 pandemic – Reperfusion therapy revisited
por: Ferreira, Jorge
Publicado: (2021)

Myocardial infarction in the COVID-19 pandemic – Reperfusion therapy revisited
por: Ferreira, Jorge
Publicado: (2021)

Questioning central assumptions of the ICAP framework
por: Thurn, Christian M., et al.
Publicado: (2023)

Mitochondrial OXPHOS influences immune cell fate: lessons from hematopoietic AIF-deficient and NDUFS4-deficient mouse models
por: Bertaux, Audrey, et al.
Publicado: (2018)

JAK/STAT Signalling in Huntington’s Disease Immune Cells
por: Träger, Ulrike, et al.
Publicado: (2013)

Of Yeast, Mice, and Men: Rab Proteins and Organelle Transport
por: Deacon, Sean W., et al.
Publicado: (2001)

Importance of retrograde axonal transport in mitochondrial health and distribution
por: Hung, Christy
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ot77mhkhkd5624ng1h298dq1dt